U.S. FDA approves J&J hepatitis C pill
November 22, 2013 at 18:50 PM EST
Nov 22 (Reuters) - U.S. regulators on Friday approved the use of Johnson & Johnson's Olysio, also known as simeprevir, as a treatment for chronic infection with the liver-destroying hepatitis C virus.
